User profiles for Xiaowei Liu

Xiaowei Liu

- Verified email at asu.edu - Cited by 1430

Xiaowei Liu

- Verified email at scu.edu.cn - Cited by 856

A 3D nitrogen‐doped graphene/TiN nanowires composite as a strong polysulfide anchor for lithium–sulfur batteries with enhanced rate performance and high areal …

Z Li, Q He, X Xu, Y Zhao, X Liu, C Zhou, D Ai… - Advanced …, 2018 - Wiley Online Library
Lithium–sulfur (Li–S) batteries have attracted remarkable attention due to their high
theoretical capacity of 1675 mAh g −1 , rich resources, inexpensiveness, and environmental …

[HTML][HTML] Delivery of infection from asymptomatic carriers of COVID-19 in a familial cluster

F Ye, S Xu, Z Rong, R Xu, X Liu, P Deng, H Liu… - International Journal of …, 2020 - Elsevier
Objectives With the ongoing outbreak of COVID-19 around the world, it has become a
worldwide health concern. One previous study reported a family cluster with an asymptomatic …

A DNA nanostructure platform for directed assembly of synthetic vaccines

X Liu, Y Xu, T Yu, C Clifford, Y Liu, H Yan, Y Chang - Nano letters, 2012 - ACS Publications
Safe and effective vaccines offer the best intervention for disease control. One strategy to
maximize vaccine immunogenicity without compromising safety is to rationally design …

Complement C3 activation is required for antiphospholipid antibody-induced fetal loss

…, SS Pierangeli, R Espinola, LE Xiaowei… - The Journal of …, 2002 - rupress.org
The antiphospholipid syndrome (APS) is characterized by recurrent fetal loss, vascular
thrombosis, and thrombocytopenia occurring in the presence of antiphospholipid (aPL) antibodies…

[PDF][PDF] Pyruvate kinase M2 regulates gene transcription by acting as a protein kinase

X Gao, H Wang, JJ Yang, X Liu, ZR Liu - Molecular cell, 2012 - cell.com
Pyruvate kinase isoform M2 (PKM2) is a glycolysis enzyme catalyzing conversion of
phosphoenolpyruvate (PEP) to pyruvate by transferring a phosphate from PEP to ADP. We report …

DNA origami as a carrier for circumvention of drug resistance

Q Jiang, C Song, J Nangreave, X Liu… - Journal of the …, 2012 - ACS Publications
Although a multitude of promising anti-cancer drugs have been developed over the past 50
years, effective delivery of the drugs to diseased cells remains a challenge. Recently, …

[PDF][PDF] Immune checkpoint HLA-E: CD94-NKG2A mediates evasion of circulating tumor cells from NK cell surveillance

X Liu, J Song, H Zhang, X Liu, F Zuo, Y Zhao, Y Zhao… - Cancer Cell, 2023 - cell.com
Circulating tumor cells (CTCs), shed by primary malignancies, function as "seeds" for distant
metastasis. However, it is still largely unknown how CTCs escape immune surveillance. …

Requirement of activation of complement C3 and C5 for antiphospholipid antibody–mediated thrombophilia

…, G Girardi, M Vega‐Ostertag, X Liu… - Arthritis & …, 2005 - Wiley Online Library
Objective Antiphospholipid antibodies (aPL) have been shown to induce thrombosis, activate
endothelial cells, and induce fetal loss. The pathogenesis of aPL‐induced thrombosis, …

Effect of cellulose, lignin, alkali and alkaline earth metallic species on biomass pyrolysis and gasification

D Lv, M Xu, X Liu, Z Zhan, Z Li, H Yao - Fuel Processing Technology, 2010 - Elsevier
Fundamental pyrolysis/gasification characteristics of natural biomass and acid-washed
biomass without alkali and alkaline earth metals (AAEM) were investigated by a …

Global liver disease burdens and research trends: analysis from a Chinese perspective

…, Y Liu, W Li, K Koike, W He, H You, Y Miao, X Liu… - Journal of …, 2019 - Elsevier
Liver diseases affect millions of people worldwide. In most developed countries, the
incidence of viral hepatitis is waning as a result of modern advances in disease prevention, …